“Glucagon-like Peptide-1 Medicines for Peripheral Arterial Disease in Type 2 Diabetes: Are They Ready for Prime Time?”, Can Diabetes Endocrinol Today, vol. 4, no. 1, pp. 5–9, May 2026, doi: 10.58931/cdet.2026.4149.